Clinical Trials In Alabama

Discover hundreds of clinical trials in Alabama.
Search clinical trials in Alabama by city, condition or phase.

e.g. Respiratory Diseases

Alabama•Healthy volunteers: No

Filter results

Results: 1,107

A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

Recruiting

Phase 1

Phase 2

Sponsor:

Xentria, Inc.

Location:

Birmingham, Denver, Jacksonville, Chicagoshow 12 more

Code:

NCT05890729

Conditions

Pulmonary Sarcoidosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

XTMAB-16 or Placebo

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

Recruiting

Phase 2

Sponsor:

Taiho Oncology, Inc.

Location:

Birmingham, Duarte, Huntington Beach, Irvineshow 22 more

Code:

NCT05967689

Conditions

Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TAS6417

A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial Cancer

Recruiting

Phase 2

Sponsor:

Hoffmann-La Roche

Location:

Birmingham, Orlando, Cleveland, Columbusshow 4 more

Code:

NCT05645692

Conditions

Urothelial Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Atezolizumab

Tobemstomig

Tiragolumab

Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma

Recruiting

Phase 2

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Birmingham, Palo Alto, New Haven, Atlantashow 53 more

Code:

NCT05303792

Conditions

B Acute Lymphoblastic Leukemia

B Lymphoblastic Lymphoma

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

Cyclophosphamide

Vincristine

Dexamethasone

Inotuzumab Ozogamicin

Methotrexate

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

Recruiting

Phase 2

Phase 3

Sponsor:

Takeda

Location:

Birmingham, Redwood City, Santa Ana, Colorado Springsshow 14 more

Code:

NCT05816382

Conditions

Narcolepsy Type 1

Eligibility Criteria

Sex: All

Age: 16 - 70

Healthy Volunteers: Not accepted

Interventions

TAK-861

Clinical Validation of ThyroidPrint: A Gene Expression Signature for Diagnosis of Indeterminate Thyroid Nodules

Recruiting

Sponsor:

Pontificia Universidad Catolica de Chile

Location:

Guntersville, Palo Alto, Tampa, New Orleansshow 2 more

Code:

NCT03309631

Conditions

Indeterminate Thyroid Cytology

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

In vitro Diagnostic

Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy

Recruiting

Phase 1

Phase 2

Sponsor:

Ferring Pharmaceuticals

Location:

Mobile, San Diego, Baltimore, Bronx

Code:

NCT04113382

Conditions

Bowel Preparation

Eligibility Criteria

Sex: All

Age: 2 - 8

Healthy Volunteers: Not accepted

Interventions

CLENPIQ

MIRALAX

MEASuRE: Metreleptin Effectiveness And Safety Registry

Recruiting

Sponsor:

Aegerion Pharmaceuticals, Inc.

Location:

Birmingham, Duarte, Atlanta, Chicagoshow 10 more

Code:

NCT02325674

Conditions

Generalised Lipodystrophy

Partial Lipodystrophy

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Metreleptin

Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers

Recruiting

Phase 2

Sponsor:

KeraCure

Location:

Montgomery, Phoenix, Tucson, Fresnoshow 17 more

Code:

NCT00330265

Conditions

Foot Ulcer

Diabetes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

KC-002

Conventional Wound Therapy

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Recruiting

Phase 3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Mobile, Los Alamitos, Thomasville, Skokieshow 6 more

Code:

NCT06393374

Conditions

Triple-Negative Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

sac-TMT

Capecitabine

e.g. Respiratory Diseases

Alabama•Healthy volunteers: No

Filter results

Results: 1,107

A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

Recruiting

Phase 1

Phase 2

Sponsor:

Xentria, Inc.

Location:

Birmingham, Denver, Jacksonville, Chicagoshow 12 more

Code:

NCT05890729

Conditions

Pulmonary Sarcoidosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

XTMAB-16 or Placebo

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

Recruiting

Phase 2

Sponsor:

Taiho Oncology, Inc.

Location:

Birmingham, Duarte, Huntington Beach, Irvineshow 22 more

Code:

NCT05967689

Conditions

Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TAS6417

A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial Cancer

Recruiting

Phase 2

Sponsor:

Hoffmann-La Roche

Location:

Birmingham, Orlando, Cleveland, Columbusshow 4 more

Code:

NCT05645692

Conditions

Urothelial Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Atezolizumab

Tobemstomig

Tiragolumab

Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma

Recruiting

Phase 2

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Birmingham, Palo Alto, New Haven, Atlantashow 53 more

Code:

NCT05303792

Conditions

B Acute Lymphoblastic Leukemia

B Lymphoblastic Lymphoma

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

Cyclophosphamide

Vincristine

Dexamethasone

Inotuzumab Ozogamicin

Methotrexate

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

Recruiting

Phase 2

Phase 3

Sponsor:

Takeda

Location:

Birmingham, Redwood City, Santa Ana, Colorado Springsshow 14 more

Code:

NCT05816382

Conditions

Narcolepsy Type 1

Eligibility Criteria

Sex: All

Age: 16 - 70

Healthy Volunteers: Not accepted

Interventions

TAK-861

Clinical Validation of ThyroidPrint: A Gene Expression Signature for Diagnosis of Indeterminate Thyroid Nodules

Recruiting

Sponsor:

Pontificia Universidad Catolica de Chile

Location:

Guntersville, Palo Alto, Tampa, New Orleansshow 2 more

Code:

NCT03309631

Conditions

Indeterminate Thyroid Cytology

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

In vitro Diagnostic

Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy

Recruiting

Phase 1

Phase 2

Sponsor:

Ferring Pharmaceuticals

Location:

Mobile, San Diego, Baltimore, Bronx

Code:

NCT04113382

Conditions

Bowel Preparation

Eligibility Criteria

Sex: All

Age: 2 - 8

Healthy Volunteers: Not accepted

Interventions

CLENPIQ

MIRALAX

MEASuRE: Metreleptin Effectiveness And Safety Registry

Recruiting

Sponsor:

Aegerion Pharmaceuticals, Inc.

Location:

Birmingham, Duarte, Atlanta, Chicagoshow 10 more

Code:

NCT02325674

Conditions

Generalised Lipodystrophy

Partial Lipodystrophy

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Metreleptin

Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers

Recruiting

Phase 2

Sponsor:

KeraCure

Location:

Montgomery, Phoenix, Tucson, Fresnoshow 17 more

Code:

NCT00330265

Conditions

Foot Ulcer

Diabetes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

KC-002

Conventional Wound Therapy

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Recruiting

Phase 3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Mobile, Los Alamitos, Thomasville, Skokieshow 6 more

Code:

NCT06393374

Conditions

Triple-Negative Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

sac-TMT

Capecitabine